nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—CYP3A4—bone cancer	0.919	1	CbGaD
Oxymorphone—Dihydrocodeine—CYP3A4—bone cancer	0.00139	0.203	CrCbGaD
Oxymorphone—Pain—Carboplatin—bone cancer	0.00119	0.0161	CcSEcCtD
Oxymorphone—Pneumothorax—Epirubicin—bone cancer	0.00118	0.016	CcSEcCtD
Oxymorphone—Body temperature increased—Carboplatin—bone cancer	0.0011	0.0149	CcSEcCtD
Oxymorphone—Pneumothorax—Doxorubicin—bone cancer	0.00109	0.0148	CcSEcCtD
Oxymorphone—Hydrocodone—CYP3A4—bone cancer	0.00106	0.156	CrCbGaD
Oxymorphone—Oxycodone—CYP3A4—bone cancer	0.000971	0.142	CrCbGaD
Oxymorphone—Buprenorphine—CYP3A4—bone cancer	0.000894	0.131	CrCbGaD
Oxymorphone—Naloxone—CYP3A4—bone cancer	0.000888	0.13	CrCbGaD
Oxymorphone—Lung disorder—Methotrexate—bone cancer	0.000887	0.012	CcSEcCtD
Oxymorphone—Amnesia—Cisplatin—bone cancer	0.000884	0.0119	CcSEcCtD
Oxymorphone—Hydromorphone—CYP3A4—bone cancer	0.000881	0.129	CrCbGaD
Oxymorphone—Ileus—Epirubicin—bone cancer	0.00083	0.0112	CcSEcCtD
Oxymorphone—Lung disorder—Epirubicin—bone cancer	0.00083	0.0112	CcSEcCtD
Oxymorphone—Dermatitis atopic—Epirubicin—bone cancer	0.000794	0.0107	CcSEcCtD
Oxymorphone—Dehydration—Cisplatin—bone cancer	0.000772	0.0104	CcSEcCtD
Oxymorphone—Ileus—Doxorubicin—bone cancer	0.000768	0.0104	CcSEcCtD
Oxymorphone—Lung disorder—Doxorubicin—bone cancer	0.000768	0.0104	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Cisplatin—bone cancer	0.000759	0.0102	CcSEcCtD
Oxymorphone—Morphine—CYP3A4—bone cancer	0.000749	0.11	CrCbGaD
Oxymorphone—Apnoea—Methotrexate—bone cancer	0.000741	0.01	CcSEcCtD
Oxymorphone—Dermatitis atopic—Doxorubicin—bone cancer	0.000734	0.00992	CcSEcCtD
Oxymorphone—Sweating increased—Cisplatin—bone cancer	0.000699	0.00945	CcSEcCtD
Oxymorphone—Oliguria—Methotrexate—bone cancer	0.000681	0.0092	CcSEcCtD
Oxymorphone—Oliguria—Epirubicin—bone cancer	0.000638	0.00861	CcSEcCtD
Oxymorphone—Depressed level of consciousness—Methotrexate—bone cancer	0.000606	0.00819	CcSEcCtD
Oxymorphone—Oliguria—Doxorubicin—bone cancer	0.00059	0.00797	CcSEcCtD
Oxymorphone—Bradycardia—Cisplatin—bone cancer	0.000585	0.0079	CcSEcCtD
Oxymorphone—Injection site reaction—Epirubicin—bone cancer	0.000584	0.00789	CcSEcCtD
Oxymorphone—Urinary tract disorder—Cisplatin—bone cancer	0.000567	0.00767	CcSEcCtD
Oxymorphone—Urethral disorder—Cisplatin—bone cancer	0.000563	0.00761	CcSEcCtD
Oxymorphone—Visual impairment—Cisplatin—bone cancer	0.000554	0.00748	CcSEcCtD
Oxymorphone—Injection site reaction—Doxorubicin—bone cancer	0.00054	0.0073	CcSEcCtD
Oxymorphone—Eye disorder—Cisplatin—bone cancer	0.000537	0.00725	CcSEcCtD
Oxymorphone—Flushing—Cisplatin—bone cancer	0.000533	0.0072	CcSEcCtD
Oxymorphone—Cardiac disorder—Cisplatin—bone cancer	0.000533	0.0072	CcSEcCtD
Oxymorphone—Immune system disorder—Cisplatin—bone cancer	0.000519	0.00701	CcSEcCtD
Oxymorphone—Mediastinal disorder—Cisplatin—bone cancer	0.000518	0.007	CcSEcCtD
Oxymorphone—Mental disability—Epirubicin—bone cancer	0.00051	0.00689	CcSEcCtD
Oxymorphone—Malnutrition—Cisplatin—bone cancer	0.0005	0.00676	CcSEcCtD
Oxymorphone—Flatulence—Cisplatin—bone cancer	0.000493	0.00666	CcSEcCtD
Oxymorphone—Visual disturbance—Methotrexate—bone cancer	0.000481	0.0065	CcSEcCtD
Oxymorphone—Mental disability—Doxorubicin—bone cancer	0.000472	0.00637	CcSEcCtD
Oxymorphone—Vision blurred—Cisplatin—bone cancer	0.000471	0.00637	CcSEcCtD
Oxymorphone—Lethargy—Methotrexate—bone cancer	0.000465	0.00628	CcSEcCtD
Oxymorphone—Hot flush—Epirubicin—bone cancer	0.000456	0.00616	CcSEcCtD
Oxymorphone—Menopausal symptoms—Epirubicin—bone cancer	0.000452	0.00611	CcSEcCtD
Oxymorphone—Lethargy—Epirubicin—bone cancer	0.000435	0.00588	CcSEcCtD
Oxymorphone—Convulsion—Cisplatin—bone cancer	0.000433	0.00585	CcSEcCtD
Oxymorphone—Diplopia—Epirubicin—bone cancer	0.000426	0.00576	CcSEcCtD
Oxymorphone—Anxiety—Cisplatin—bone cancer	0.000424	0.00573	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000423	0.00571	CcSEcCtD
Oxymorphone—Hot flush—Doxorubicin—bone cancer	0.000422	0.0057	CcSEcCtD
Oxymorphone—Menopausal symptoms—Doxorubicin—bone cancer	0.000418	0.00565	CcSEcCtD
Oxymorphone—Oedema—Cisplatin—bone cancer	0.000408	0.00551	CcSEcCtD
Oxymorphone—Lethargy—Doxorubicin—bone cancer	0.000403	0.00544	CcSEcCtD
Oxymorphone—Nervous system disorder—Cisplatin—bone cancer	0.0004	0.00541	CcSEcCtD
Oxymorphone—Tachycardia—Cisplatin—bone cancer	0.000398	0.00538	CcSEcCtD
Oxymorphone—Dehydration—Epirubicin—bone cancer	0.000397	0.00536	CcSEcCtD
Oxymorphone—Skin disorder—Cisplatin—bone cancer	0.000396	0.00536	CcSEcCtD
Oxymorphone—Diplopia—Doxorubicin—bone cancer	0.000395	0.00533	CcSEcCtD
Oxymorphone—Hyperhidrosis—Cisplatin—bone cancer	0.000395	0.00533	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Epirubicin—bone cancer	0.00039	0.00526	CcSEcCtD
Oxymorphone—Anorexia—Cisplatin—bone cancer	0.000389	0.00526	CcSEcCtD
Oxymorphone—Hypotension—Cisplatin—bone cancer	0.000381	0.00515	CcSEcCtD
Oxymorphone—Abdominal distension—Epirubicin—bone cancer	0.000371	0.00501	CcSEcCtD
Oxymorphone—Dehydration—Doxorubicin—bone cancer	0.000367	0.00496	CcSEcCtD
Oxymorphone—Dyspnoea—Cisplatin—bone cancer	0.000364	0.00492	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Doxorubicin—bone cancer	0.00036	0.00487	CcSEcCtD
Oxymorphone—Decreased appetite—Cisplatin—bone cancer	0.000355	0.00479	CcSEcCtD
Oxymorphone—Pneumonia—Methotrexate—bone cancer	0.000353	0.00477	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Cisplatin—bone cancer	0.000352	0.00476	CcSEcCtD
Oxymorphone—Pain—Cisplatin—bone cancer	0.000349	0.00472	CcSEcCtD
Oxymorphone—Abdominal distension—Doxorubicin—bone cancer	0.000343	0.00464	CcSEcCtD
Oxymorphone—Feeling abnormal—Cisplatin—bone cancer	0.000336	0.00454	CcSEcCtD
Oxymorphone—Weight decreased—Epirubicin—bone cancer	0.000333	0.00451	CcSEcCtD
Oxymorphone—Pneumonia—Epirubicin—bone cancer	0.000331	0.00447	CcSEcCtD
Oxymorphone—Body temperature increased—Cisplatin—bone cancer	0.000323	0.00436	CcSEcCtD
Oxymorphone—Urinary tract disorder—Methotrexate—bone cancer	0.000311	0.00421	CcSEcCtD
Oxymorphone—Urethral disorder—Methotrexate—bone cancer	0.000309	0.00418	CcSEcCtD
Oxymorphone—Weight decreased—Doxorubicin—bone cancer	0.000309	0.00417	CcSEcCtD
Oxymorphone—Pneumonia—Doxorubicin—bone cancer	0.000306	0.00413	CcSEcCtD
Oxymorphone—Visual impairment—Methotrexate—bone cancer	0.000304	0.0041	CcSEcCtD
Oxymorphone—Hypersensitivity—Cisplatin—bone cancer	0.000301	0.00406	CcSEcCtD
Oxymorphone—Bradycardia—Epirubicin—bone cancer	0.0003	0.00406	CcSEcCtD
Oxymorphone—Eye disorder—Methotrexate—bone cancer	0.000295	0.00398	CcSEcCtD
Oxymorphone—Asthenia—Cisplatin—bone cancer	0.000293	0.00396	CcSEcCtD
Oxymorphone—Cardiac disorder—Methotrexate—bone cancer	0.000293	0.00395	CcSEcCtD
Oxymorphone—Urinary tract disorder—Epirubicin—bone cancer	0.000291	0.00394	CcSEcCtD
Oxymorphone—Urethral disorder—Epirubicin—bone cancer	0.000289	0.00391	CcSEcCtD
Oxymorphone—Angiopathy—Methotrexate—bone cancer	0.000286	0.00386	CcSEcCtD
Oxymorphone—Immune system disorder—Methotrexate—bone cancer	0.000285	0.00385	CcSEcCtD
Oxymorphone—Visual impairment—Epirubicin—bone cancer	0.000284	0.00384	CcSEcCtD
Oxymorphone—Mediastinal disorder—Methotrexate—bone cancer	0.000284	0.00384	CcSEcCtD
Oxymorphone—Diarrhoea—Cisplatin—bone cancer	0.000279	0.00377	CcSEcCtD
Oxymorphone—Bradycardia—Doxorubicin—bone cancer	0.000278	0.00375	CcSEcCtD
Oxymorphone—Mental disorder—Methotrexate—bone cancer	0.000276	0.00373	CcSEcCtD
Oxymorphone—Eye disorder—Epirubicin—bone cancer	0.000276	0.00373	CcSEcCtD
Oxymorphone—Malnutrition—Methotrexate—bone cancer	0.000274	0.00371	CcSEcCtD
Oxymorphone—Cardiac disorder—Epirubicin—bone cancer	0.000274	0.0037	CcSEcCtD
Oxymorphone—Flushing—Epirubicin—bone cancer	0.000274	0.0037	CcSEcCtD
Oxymorphone—Urinary tract disorder—Doxorubicin—bone cancer	0.00027	0.00364	CcSEcCtD
Oxymorphone—Angiopathy—Epirubicin—bone cancer	0.000268	0.00362	CcSEcCtD
Oxymorphone—Urethral disorder—Doxorubicin—bone cancer	0.000268	0.00362	CcSEcCtD
Oxymorphone—Immune system disorder—Epirubicin—bone cancer	0.000266	0.0036	CcSEcCtD
Oxymorphone—Mediastinal disorder—Epirubicin—bone cancer	0.000266	0.00359	CcSEcCtD
Oxymorphone—Visual impairment—Doxorubicin—bone cancer	0.000263	0.00355	CcSEcCtD
Oxymorphone—Vomiting—Cisplatin—bone cancer	0.00026	0.00351	CcSEcCtD
Oxymorphone—Vision blurred—Methotrexate—bone cancer	0.000259	0.00349	CcSEcCtD
Oxymorphone—Mental disorder—Epirubicin—bone cancer	0.000258	0.00349	CcSEcCtD
Oxymorphone—Dermatitis—Cisplatin—bone cancer	0.000257	0.00347	CcSEcCtD
Oxymorphone—Malnutrition—Epirubicin—bone cancer	0.000257	0.00347	CcSEcCtD
Oxymorphone—Eye disorder—Doxorubicin—bone cancer	0.000255	0.00345	CcSEcCtD
Oxymorphone—Flushing—Doxorubicin—bone cancer	0.000253	0.00342	CcSEcCtD
Oxymorphone—Cardiac disorder—Doxorubicin—bone cancer	0.000253	0.00342	CcSEcCtD
Oxymorphone—Flatulence—Epirubicin—bone cancer	0.000253	0.00342	CcSEcCtD
Oxymorphone—Tension—Epirubicin—bone cancer	0.000252	0.00341	CcSEcCtD
Oxymorphone—Nervousness—Epirubicin—bone cancer	0.000249	0.00337	CcSEcCtD
Oxymorphone—Angiopathy—Doxorubicin—bone cancer	0.000248	0.00335	CcSEcCtD
Oxymorphone—Immune system disorder—Doxorubicin—bone cancer	0.000247	0.00333	CcSEcCtD
Oxymorphone—Vertigo—Methotrexate—bone cancer	0.000247	0.00333	CcSEcCtD
Oxymorphone—Mediastinal disorder—Doxorubicin—bone cancer	0.000246	0.00332	CcSEcCtD
Oxymorphone—Nausea—Cisplatin—bone cancer	0.000242	0.00328	CcSEcCtD
Oxymorphone—Vision blurred—Epirubicin—bone cancer	0.000242	0.00327	CcSEcCtD
Oxymorphone—Mental disorder—Doxorubicin—bone cancer	0.000239	0.00323	CcSEcCtD
Oxymorphone—Convulsion—Methotrexate—bone cancer	0.000238	0.00321	CcSEcCtD
Oxymorphone—Malnutrition—Doxorubicin—bone cancer	0.000238	0.00321	CcSEcCtD
Oxymorphone—Agitation—Epirubicin—bone cancer	0.000236	0.00319	CcSEcCtD
Oxymorphone—Flatulence—Doxorubicin—bone cancer	0.000234	0.00316	CcSEcCtD
Oxymorphone—Chest pain—Methotrexate—bone cancer	0.000234	0.00316	CcSEcCtD
Oxymorphone—Tension—Doxorubicin—bone cancer	0.000233	0.00315	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000232	0.00314	CcSEcCtD
Oxymorphone—Nervousness—Doxorubicin—bone cancer	0.000231	0.00312	CcSEcCtD
Oxymorphone—Vertigo—Epirubicin—bone cancer	0.000231	0.00312	CcSEcCtD
Oxymorphone—Syncope—Epirubicin—bone cancer	0.00023	0.00311	CcSEcCtD
Oxymorphone—Palpitations—Epirubicin—bone cancer	0.000227	0.00307	CcSEcCtD
Oxymorphone—Confusional state—Methotrexate—bone cancer	0.000226	0.00305	CcSEcCtD
Oxymorphone—Loss of consciousness—Epirubicin—bone cancer	0.000226	0.00305	CcSEcCtD
Oxymorphone—Vision blurred—Doxorubicin—bone cancer	0.000224	0.00303	CcSEcCtD
Oxymorphone—Convulsion—Epirubicin—bone cancer	0.000223	0.00301	CcSEcCtD
Oxymorphone—Hypertension—Epirubicin—bone cancer	0.000222	0.003	CcSEcCtD
Oxymorphone—Nervous system disorder—Methotrexate—bone cancer	0.00022	0.00297	CcSEcCtD
Oxymorphone—Chest pain—Epirubicin—bone cancer	0.000219	0.00295	CcSEcCtD
Oxymorphone—Agitation—Doxorubicin—bone cancer	0.000218	0.00295	CcSEcCtD
Oxymorphone—Anxiety—Epirubicin—bone cancer	0.000218	0.00294	CcSEcCtD
Oxymorphone—Skin disorder—Methotrexate—bone cancer	0.000218	0.00294	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000217	0.00293	CcSEcCtD
Oxymorphone—Hyperhidrosis—Methotrexate—bone cancer	0.000217	0.00293	CcSEcCtD
Oxymorphone—Dry mouth—Epirubicin—bone cancer	0.000214	0.00289	CcSEcCtD
Oxymorphone—Vertigo—Doxorubicin—bone cancer	0.000214	0.00288	CcSEcCtD
Oxymorphone—Anorexia—Methotrexate—bone cancer	0.000214	0.00288	CcSEcCtD
Oxymorphone—Syncope—Doxorubicin—bone cancer	0.000213	0.00288	CcSEcCtD
Oxymorphone—Confusional state—Epirubicin—bone cancer	0.000211	0.00286	CcSEcCtD
Oxymorphone—Palpitations—Doxorubicin—bone cancer	0.00021	0.00284	CcSEcCtD
Oxymorphone—Oedema—Epirubicin—bone cancer	0.00021	0.00283	CcSEcCtD
Oxymorphone—Hypotension—Methotrexate—bone cancer	0.000209	0.00283	CcSEcCtD
Oxymorphone—Loss of consciousness—Doxorubicin—bone cancer	0.000209	0.00282	CcSEcCtD
Oxymorphone—Shock—Epirubicin—bone cancer	0.000206	0.00279	CcSEcCtD
Oxymorphone—Convulsion—Doxorubicin—bone cancer	0.000206	0.00278	CcSEcCtD
Oxymorphone—Nervous system disorder—Epirubicin—bone cancer	0.000206	0.00278	CcSEcCtD
Oxymorphone—Hypertension—Doxorubicin—bone cancer	0.000205	0.00277	CcSEcCtD
Oxymorphone—Tachycardia—Epirubicin—bone cancer	0.000205	0.00276	CcSEcCtD
Oxymorphone—Skin disorder—Epirubicin—bone cancer	0.000204	0.00275	CcSEcCtD
Oxymorphone—Hyperhidrosis—Epirubicin—bone cancer	0.000203	0.00274	CcSEcCtD
Oxymorphone—Insomnia—Methotrexate—bone cancer	0.000203	0.00274	CcSEcCtD
Oxymorphone—Chest pain—Doxorubicin—bone cancer	0.000202	0.00273	CcSEcCtD
Oxymorphone—Anxiety—Doxorubicin—bone cancer	0.000202	0.00272	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000201	0.00271	CcSEcCtD
Oxymorphone—Anorexia—Epirubicin—bone cancer	0.0002	0.0027	CcSEcCtD
Oxymorphone—Dyspnoea—Methotrexate—bone cancer	0.0002	0.0027	CcSEcCtD
Oxymorphone—Somnolence—Methotrexate—bone cancer	0.000199	0.00269	CcSEcCtD
Oxymorphone—Dry mouth—Doxorubicin—bone cancer	0.000198	0.00267	CcSEcCtD
Oxymorphone—Dyspepsia—Methotrexate—bone cancer	0.000197	0.00266	CcSEcCtD
Oxymorphone—Hypotension—Epirubicin—bone cancer	0.000196	0.00265	CcSEcCtD
Oxymorphone—Confusional state—Doxorubicin—bone cancer	0.000196	0.00264	CcSEcCtD
Oxymorphone—Decreased appetite—Methotrexate—bone cancer	0.000195	0.00263	CcSEcCtD
Oxymorphone—Oedema—Doxorubicin—bone cancer	0.000194	0.00262	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Methotrexate—bone cancer	0.000193	0.00261	CcSEcCtD
Oxymorphone—Fatigue—Methotrexate—bone cancer	0.000193	0.00261	CcSEcCtD
Oxymorphone—Pain—Methotrexate—bone cancer	0.000192	0.00259	CcSEcCtD
Oxymorphone—Shock—Doxorubicin—bone cancer	0.000191	0.00258	CcSEcCtD
Oxymorphone—Nervous system disorder—Doxorubicin—bone cancer	0.00019	0.00257	CcSEcCtD
Oxymorphone—Insomnia—Epirubicin—bone cancer	0.00019	0.00256	CcSEcCtD
Oxymorphone—Tachycardia—Doxorubicin—bone cancer	0.000189	0.00256	CcSEcCtD
Oxymorphone—Skin disorder—Doxorubicin—bone cancer	0.000188	0.00255	CcSEcCtD
Oxymorphone—Hyperhidrosis—Doxorubicin—bone cancer	0.000187	0.00253	CcSEcCtD
Oxymorphone—Dyspnoea—Epirubicin—bone cancer	0.000187	0.00252	CcSEcCtD
Oxymorphone—Somnolence—Epirubicin—bone cancer	0.000186	0.00252	CcSEcCtD
Oxymorphone—Anorexia—Doxorubicin—bone cancer	0.000185	0.0025	CcSEcCtD
Oxymorphone—Feeling abnormal—Methotrexate—bone cancer	0.000185	0.00249	CcSEcCtD
Oxymorphone—Dyspepsia—Epirubicin—bone cancer	0.000185	0.00249	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Methotrexate—bone cancer	0.000183	0.00247	CcSEcCtD
Oxymorphone—Decreased appetite—Epirubicin—bone cancer	0.000182	0.00246	CcSEcCtD
Oxymorphone—Hypotension—Doxorubicin—bone cancer	0.000181	0.00245	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Epirubicin—bone cancer	0.000181	0.00245	CcSEcCtD
Oxymorphone—Fatigue—Epirubicin—bone cancer	0.000181	0.00244	CcSEcCtD
Oxymorphone—Pain—Epirubicin—bone cancer	0.000179	0.00242	CcSEcCtD
Oxymorphone—Constipation—Epirubicin—bone cancer	0.000179	0.00242	CcSEcCtD
Oxymorphone—Urticaria—Methotrexate—bone cancer	0.000178	0.0024	CcSEcCtD
Oxymorphone—Abdominal pain—Methotrexate—bone cancer	0.000177	0.00239	CcSEcCtD
Oxymorphone—Body temperature increased—Methotrexate—bone cancer	0.000177	0.00239	CcSEcCtD
Oxymorphone—Insomnia—Doxorubicin—bone cancer	0.000175	0.00237	CcSEcCtD
Oxymorphone—Dyspnoea—Doxorubicin—bone cancer	0.000173	0.00234	CcSEcCtD
Oxymorphone—Feeling abnormal—Epirubicin—bone cancer	0.000173	0.00233	CcSEcCtD
Oxymorphone—Somnolence—Doxorubicin—bone cancer	0.000172	0.00233	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Epirubicin—bone cancer	0.000171	0.00232	CcSEcCtD
Oxymorphone—Dyspepsia—Doxorubicin—bone cancer	0.000171	0.00231	CcSEcCtD
Oxymorphone—Decreased appetite—Doxorubicin—bone cancer	0.000169	0.00228	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000167	0.00226	CcSEcCtD
Oxymorphone—Fatigue—Doxorubicin—bone cancer	0.000167	0.00226	CcSEcCtD
Oxymorphone—Urticaria—Epirubicin—bone cancer	0.000167	0.00225	CcSEcCtD
Oxymorphone—Pain—Doxorubicin—bone cancer	0.000166	0.00224	CcSEcCtD
Oxymorphone—Constipation—Doxorubicin—bone cancer	0.000166	0.00224	CcSEcCtD
Oxymorphone—Body temperature increased—Epirubicin—bone cancer	0.000166	0.00224	CcSEcCtD
Oxymorphone—Abdominal pain—Epirubicin—bone cancer	0.000166	0.00224	CcSEcCtD
Oxymorphone—Hypersensitivity—Methotrexate—bone cancer	0.000165	0.00223	CcSEcCtD
Oxymorphone—Asthenia—Methotrexate—bone cancer	0.000161	0.00217	CcSEcCtD
Oxymorphone—Feeling abnormal—Doxorubicin—bone cancer	0.00016	0.00216	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Doxorubicin—bone cancer	0.000159	0.00214	CcSEcCtD
Oxymorphone—Pruritus—Methotrexate—bone cancer	0.000158	0.00214	CcSEcCtD
Oxymorphone—Hypersensitivity—Epirubicin—bone cancer	0.000154	0.00209	CcSEcCtD
Oxymorphone—Urticaria—Doxorubicin—bone cancer	0.000154	0.00208	CcSEcCtD
Oxymorphone—Abdominal pain—Doxorubicin—bone cancer	0.000153	0.00207	CcSEcCtD
Oxymorphone—Body temperature increased—Doxorubicin—bone cancer	0.000153	0.00207	CcSEcCtD
Oxymorphone—Diarrhoea—Methotrexate—bone cancer	0.000153	0.00207	CcSEcCtD
Oxymorphone—Asthenia—Epirubicin—bone cancer	0.00015	0.00203	CcSEcCtD
Oxymorphone—Pruritus—Epirubicin—bone cancer	0.000148	0.002	CcSEcCtD
Oxymorphone—Dizziness—Methotrexate—bone cancer	0.000148	0.002	CcSEcCtD
Oxymorphone—Diarrhoea—Epirubicin—bone cancer	0.000143	0.00194	CcSEcCtD
Oxymorphone—Hypersensitivity—Doxorubicin—bone cancer	0.000143	0.00193	CcSEcCtD
Oxymorphone—Vomiting—Methotrexate—bone cancer	0.000142	0.00192	CcSEcCtD
Oxymorphone—Dermatitis—Methotrexate—bone cancer	0.000141	0.00191	CcSEcCtD
Oxymorphone—Headache—Methotrexate—bone cancer	0.00014	0.0019	CcSEcCtD
Oxymorphone—Asthenia—Doxorubicin—bone cancer	0.000139	0.00188	CcSEcCtD
Oxymorphone—Dizziness—Epirubicin—bone cancer	0.000139	0.00187	CcSEcCtD
Oxymorphone—Pruritus—Doxorubicin—bone cancer	0.000137	0.00185	CcSEcCtD
Oxymorphone—Vomiting—Epirubicin—bone cancer	0.000133	0.0018	CcSEcCtD
Oxymorphone—Nausea—Methotrexate—bone cancer	0.000133	0.0018	CcSEcCtD
Oxymorphone—Diarrhoea—Doxorubicin—bone cancer	0.000133	0.00179	CcSEcCtD
Oxymorphone—Dermatitis—Epirubicin—bone cancer	0.000132	0.00178	CcSEcCtD
Oxymorphone—Headache—Epirubicin—bone cancer	0.000131	0.00177	CcSEcCtD
Oxymorphone—Dizziness—Doxorubicin—bone cancer	0.000128	0.00173	CcSEcCtD
Oxymorphone—Nausea—Epirubicin—bone cancer	0.000125	0.00168	CcSEcCtD
Oxymorphone—Vomiting—Doxorubicin—bone cancer	0.000123	0.00167	CcSEcCtD
Oxymorphone—Dermatitis—Doxorubicin—bone cancer	0.000122	0.00165	CcSEcCtD
Oxymorphone—Headache—Doxorubicin—bone cancer	0.000122	0.00164	CcSEcCtD
Oxymorphone—Nausea—Doxorubicin—bone cancer	0.000115	0.00156	CcSEcCtD
